Gender-related immune-inflammatory factors, age-related diseases, and longevity

Rejuvenation Research

Volumn 13, Issue 2-3, 2010, Pages 292-297

  Candore, Giuseppina ^a   Balistreri, Carmela Rita ^a   Colonna Romano, Giuseppina ^a   Lio, Domenico ^a   Listì, Florinda ^a   Vasto, Sonya ^a   Caruso, Calogero ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SEX HORMONE; TAU PROTEIN; UBIQUITIN;

AGE DISTRIBUTION; ALZHEIMER DISEASE; ANGIOGENESIS; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASTROCYTE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BRAIN ATROPHY; BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; CELL LOSS; CELL MEMBRANE; CELL STIMULATION; CHRONIC INFLAMMATION; COGNITIVE DEFECT; CYTOKINE RELEASE; CYTOPLASM; DEMENTIA; DENDRITE; DENDRITIC CELL; DIFFUSION; DISEASE COURSE; EDUCATIONAL STATUS; ENZYME ACTIVATION; ESTROGEN BLOOD LEVEL; ESTROGEN RESPONSIVE ELEMENT; FIBROBLAST; FOLLICULAR PHASE; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; GERIATRIC DISORDER; GLIA CELL; GLUCOSE TRANSPORT; HIPPOCAMPUS; HORMONAL THERAPY; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; LIFESPAN; LIMBIC CORTEX; LONGEVITY; LUTEAL PHASE; LYMPHOCYTE; MACROPHAGE; MENOPAUSE; MICROENVIRONMENT; MICROGLIA; MONOCYTE; MORTALITY; NERVE CELL; NERVE FIBER DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUTROPHIL; OVARY; OVARY FOLLICLE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PERIODONTITIS; PLACENTA; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN AGGREGATION; RESPIRATORY CHAIN; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SENILE PLAQUE; SEX DIFFERENCE; SEX RATIO; SIGNAL TRANSDUCTION; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TARDIVE DYSKINESIA; TEMPORAL CORTEX;

EID: 77952347333     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2009.0942     Document Type: Review

References (61)

1. Angele MK, Frantz MC, Chaudry IH. Gender and sex hormones influence the response to trauma and sepsis: Potential therapeutic approaches. Clinics 2006;61:479-488.
2. Raju R, Bland KI, Chaudry IH. Estrogen: A novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations. Mol Med 2008;14:213-221.
3. Qiao X, McConnell KR, Khalil RA. Sex steroids and vascular responses in hypertension and aging. Gend Med 2008; 5(Suppl A):S46-S64.
4. Chakrabarti S, Lekontseva O, Davidge ST. Estrogen is a modulator of vascular inflammation. IUBMB Life 2008;60: 376-382.
5. Członkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 2006;29:243-256.
6. Nilsson BO. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res 2007;56:269-273.
7. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521-574.
8. Candore G, Balistreri CR, Grimaldi MP, Vasto S, List̀? F, Chiappelli M, Licastro F, Lio D, Caruso C. Age-related inflammatory diseases: Role of genetics and gender in the pathophysiology of Alzheimer's disease. Ann NY Acad Sci 2006;1089:472-486.
9. Di Bona D, Scapagnini G, Candore G, Castiglia L, Colonna-Romano G, Duro G, Iemolo F, Lio D, Pellicanò M, Scafidi V, Caruso C, Vasto S. Immune-inflammatory responses and oxidative stress in Alzheimer'disease: Therapeutic implications. Curr Pharm Des 2009 (in press).
10. Aronson MK, Ooi WL, Geva DL, Masur D, Blau A, Frishman W. Dementia. Age-dependent incidence, prevalence, and mortality in the old old. Arch Intern Med 1991;151:989-992.
11. Trojanowski JQ, Clark CM, Schmidt ML, Arnold SE, Lee VM. Strategies for improving the postmortem neuropatho-logical diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S75-S79.
12. Selkoe DJ Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 2001;81:741-766.
13. Vasto S, Candore G, Duro G, Lio D, Grimaldi MP, Caruso C. Alzheimer's disease and genetics of inflammation: A phar-macogenomic vision. Pharmacogenomics. 2007;8:1735-1745.
14. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health And Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
15. Hy LX, Keller DM. Prevalence of AD among whites: A summary by levels of severity. Neurology 2000;55:198-204.
16. Vasto S, Candore G, List?̀ F, Balistreri CR, Colonna-Romano G, Malavolta M, Lio D, Nuzzo D, Mocchegiani E, Di Bona D, Caruso C.Inflammation, genes and zinc in Alzheimer's disease. Brain Res Rev 2008;58:96-105.
17. Gao S. Hendrie HC, Hall KS, Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis. Arch Gen Psychiatry 1998;55:809-815.
18. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURO-DEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999;52:78-84.
19. Henderson VW. Estrogen-containing hormone therapy and Alzheimer's disease risk: Understanding discrepant inferences from observational and experimental research. Neu-roscience 2006;138:1031-1039.
20. Bedard P, Langelier P, Villeneuve A. Estrogens and the ex-trapyramidal system. Lancet 1977;2:1367-1368.
21. Cyr M, Calon F, Morissette M, Di Paolo T. Estrogenic modulation of brain activity: Implications for schizophrenia and Parkinson's disease. J Psychiatry Neurosci 2002;27:12-27.
22. Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol 2004;61:886-888.
23. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996;156:2213-2217. (Pubitemid 26361914)
24. Henderson, VW. Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease. CNS Drugs 1997;8:343-351.
25. Brinton RD. Impact of estrogen therapy on Alzheimer's: A fork in the road? CNS Drugs 2004;18:405-422.
26. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and-beta mRNA in the rat central nervous system. J Comp Neurol 1997;388:507-525.
27. Toran-Allerand CD. Minireview: A plethora of estrogen receptors in the brain: Where will it end? Endocrinology 2004; 145:1069-1074.
28. Henderson VW. Hormone Therapy and the Brain: A Clinical Perspective on the Role of Estrogen. Parthenon Publishing, New York, 2000.
29. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD, Miller VM. Neuroprotective effects of female gonadal steroids in re-productively senescent female rats. Stroke 2000;31:161-168.
30. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxi-dative injury, and amyloid beta-peptide toxicity in hippo-campal neurons. J Neurochem 1996;66:1836-1844.
31. Brinton RD, Tran J, Proffitt P, Montoya M. 17 beta-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 1997;22:1339-1351.
32. Foy MR, Baudry M, Diaz Brinton R, Thompson RF. Estrogen and hippocampal plasticity in rodent models. J Alzheimers Dis 2008;15:589-603.
33. Ohkura, T. et al. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 1995;2: 13-18.
34. Bishop J, Simpkins JW. Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res Bull 1995;36:315-320.
35. Petanceska SS, Nagy V, Frail D, Gandy S. Ovariectomy and 17 beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology 2000;54:2212-2217.
36. Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP. Effect of post-menopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen=Progestin Interventions (PEPI) Study. Circulation 1999;100:717-722.
37. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP.et al. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002;22:201-210.
38. Beal MF Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998;1366:211-223.
39. Nilsen J. Estradiol and neurodegenerative oxidative stress. Front Neuroendocrinol 2008;29:463-475.
40. Borrás C, Sastre J, Garć?a-Sala D, Lloret A, Pallardó FV, Viñ a J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003;34:546-552.
41. Smith MA, Drew KL, Nunomura A, Takeda A, Hirai K, Zhu X, Atwood CS, Raina AK, Rottkamp CA, Sayre LM, Fried-land RP, Perry G. Amyloid-beta, tau alterations and mito-chondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem Int 2002;40:527-531.
42. Ryan J, Scali J, Carriere I, Ritchie K, Ancelin ML. Hormonal treatment, mild cognitive impairment and Alzheimer's disease. Int Psychogeriatr 2008;20:47-56.
43. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 1998;279:688-695.
44. Hogervorst, E. Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: A meta-analysis. Neuroscience 2000;101:485-512.
45. LeBlanc ES, Janowsky J, Chan BK, Nelson HD.Hormone replacement therapy and cognition: Systematic review and meta-analysis. JAMA 2001;285:1489-1499.
46. Maki P, Hogervorst E. The menopause and HRT. HRT and cognitive decline. Best Pract Res Clin Endocrinol Metab 2003;17:105-122.
47. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.
48. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, Women's Health Initiative Memory Study. Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291: 2947-2958.
49. www.istat.it
50. Viña J, Borrás C, Gambini J, Sastre J, Pallardó FV. Why females live longer than males: Control of longevity by sex hormones. Sci Aging Knowledge Environ 2005;2005:pe17.
51. May RC. Gender, immunity and the regulation of longevity. Bioessays 2007;29:795-802.
52. Candore G, Balistreri CR, List̀? F, Grimaldi MP, Vasto S, Colonna-Romano G, Franceschi C, Lio D, Caselli G, Caruso C. Immunogenetics, gender, and longevity. Ann NY Acad Sci 2006;1089:516-537.
53. Franceschi C, Motta L, Motta M, Malaguarnera M, Capri M, Vasto S, Candore G, Caruso C; IMUSCE. The extreme longevity: The state of the art in Italy. Exp Gerontol 2008;43: 45-52.
54. Capri M, Salvioli S, Monti D, Caruso C, Candore G, Vasto S, Olivieri F, Marchegiani F, Sansoni P, Baggio G, Mari D, Passarino G, De Benedictis G, Franceschi C. Human longevity within an evolutionary perspective: The peculiar paradigm of a post-reproductive genetics. Exp Gerontol 2008;43:53-60.
55. Carru C, Pes GM, Deiana L, Baggio G, Franceschi C, Lio D, Balistreri CR, Candore G, Colonna-Romano G, Caruso C. Association between the HFE mutations and longevity: A study in Sardinian population. Mech Ageing Dev 2003;124: 529-532. (Pubitemid 36514909)
56. Lio D, Balistreri CR, Colonna-Romano G, Motta M, Fran-ceschi C, Malaguarnera M, Candore G, Caruso C. Association between the MHC class I gene HFE polymorphisms and longevity: A study in Sicilian population. Genes Immun 2002;3:20-24.
57. Balistreri CR, Candore G, Almasio P, Di Marco V, Colonna-Romano G, Craxi A, Motta M, Piazza G, Malaguarnera M, Lio D, Caruso C. Analysis of hemochromatosis gene mutations in the Sicilian population: Implications for survival and longevity. Arch Gerontol Geriatr Suppl 2002;8:35-42.
58. Rigby JE, Dorling D. Mortality in relation to sex in the affluent world. J Epidemiol Community Health 2007;61: 159-164.
59. Bü rkle A, Caselli G, Franceschi C, Mariani E, Sansoni P, Santoni A, Vecchio G, Witkowski JM, Caruso C. Pathophy-siology of ageing, longevity and age related diseases. Im-mun Ageing 2007;4:4.
60. Jirillo E, Candore G, Magrone T, Caruso C. A scientific approach to ti-ageing therapies: State of the art. Curr Pharm Des. 2008;14:2637-2642.
61. de Grey AD. Consolidating the mission to defeat aging: A big step forward. Rejuvenation Res 2008;11:1061-1063.